PortfoliosLab logoPortfoliosLab logo
ISIN
US1266501006
CUSIP
126650100
IPO Date
Dec 17, 1984

Highlights

Market Cap
$133.25B
Enterprise Value
$206.53B
EPS (TTM)
$2.30
PE Ratio
45.41
Total Revenue (TTM)
$407.91B
Gross Profit (TTM)
$56.59B
EBITDA (TTM)
$9.99B
Year Range
$61.35 - $110.68
Target Price
$95.20
ROA (TTM)
1.16%
ROE (TTM)
3.79%
Avg. Volume (1M)
7M
Avg. Volume Value (1M)
$795.56M

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

CVS Performance Chart

CVS Health Corporation (CVS) is up 34.7% since the beginning of the year. At $104 per share, CVS is trading 5.6% below its 52-week high of $111. Investors who bought $1,000 worth of CVS shares 5 years ago would now be looking at an investment worth $1,497.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

CVS Health Corporation (CVS) has returned 34.67% so far this year and 72.47% over the past 12 months. Over the last ten years, CVS has returned 3.79% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.


CVS Health Corporation

1D
-0.75%
1M
0.34%
6M
42.24%
YTD
34.67%
1Y
72.47%
3Y*
16.56%
5Y*
8.40%
10Y*
3.79%
ALL TIME*
10.07%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CVS Monthly Returns History

Based on dividend-adjusted daily data since Dec 17, 1984, CVS's average daily return is +0.06%, while the average monthly return is +1.10%. At this rate, an investment would double in approximately 5.3 years.

Historically, 54% of months were positive and 46% were negative. The best month was Jan 2025 with a return of +27.4%, while the worst month was Jun 2001 at -29.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, CVS closed higher 49% of trading days. The best single day was Oct 6, 1999 with a return of +18.2%, while the worst single day was Oct 30, 2001 at -23.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-5.33%7.22%-10.11%16.99%9.23%13.71%1.57%34.67%
202527.42%16.36%3.09%-0.52%-4.00%7.71%-8.99%17.79%3.06%4.51%2.83%-1.24%84.35%
2024-4.96%0.00%7.25%-14.29%-11.98%-0.91%3.30%-5.12%9.85%-9.21%6.00%-25.00%-40.77%
2023-4.68%-5.30%-11.05%-0.53%-7.20%1.62%8.93%-12.75%7.14%-0.31%-1.54%16.20%-12.53%
20223.80%-2.69%-2.35%-4.53%0.64%-4.23%3.86%2.58%-2.83%-0.10%7.58%-8.53%-7.63%
20215.61%-4.91%10.42%2.22%13.14%-3.47%-0.70%4.89%-1.77%5.82%-0.25%15.83%54.87%

Benchmark Metrics

CVS Health Corporation has an annualized alpha of 6.27%, beta of 0.73, and R2 of 0.20 versus S&P 500 Index. Calculated based on daily prices since December 17, 1984.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (92.81%) than losses (90.24%) - typical of diversified or defensive assets.
  • R2 of 0.20 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
6.27%
Beta
0.73
0.20
Upside Capture
92.81%
Downside Capture
90.24%

Return for Risk

Risk / Return Rank

CVS ranks 93 for risk / return — above 93% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.


CVS Risk / Return Rank: 9393
Overall Rank
CVS Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 9090
Sortino Ratio Rank
CVS Omega Ratio Rank: 9494
Omega Ratio Rank
CVS Calmar Ratio Rank: 9494
Calmar Ratio Rank
CVS Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for CVS Health Corporation (CVS) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CVSBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+1.01

Sortino ratioReturn per unit of downside risk

+0.83

Omega ratioGain probability vs. loss probability

1.43

1.25

+0.18

Calmar ratioReturn relative to maximum drawdown

4.49

2.00

+2.49

Martin ratioReturn relative to average drawdown

13.03

8.49

+4.53

Dividends

Dividend History

CVS Health Corporation provided a 2.55% dividend yield over the last twelve months, with an annual payout of $2.66 per share. The company has been increasing its dividends for 24 consecutive years.


1.00%2.00%3.00%4.00%5.00%6.00%$0.00$0.50$1.00$1.50$2.00$2.5020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$2.66$2.66$2.66$2.42$2.20$2.00$2.00$2.00$2.00$2.00$1.70$1.40

Dividend yield

2.55%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%

Monthly Dividends

The table displays the monthly dividend distributions for CVS Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.67$0.00$0.00$0.67$0.00$0.00$0.67$2.00
2025$0.67$0.00$0.00$0.67$0.00$0.00$0.67$0.00$0.00$0.67$0.00$0.00$2.66
2024$0.67$0.00$0.00$0.67$0.00$0.00$0.67$0.00$0.00$0.67$0.00$0.00$2.66
2023$0.61$0.00$0.00$0.61$0.00$0.00$0.61$0.00$0.00$0.61$0.00$0.00$2.42
2022$0.55$0.00$0.00$0.55$0.00$0.00$0.55$0.00$0.00$0.55$0.00$0.00$2.20
2021$0.50$0.00$0.00$0.50$0.00$0.00$0.50$0.00$0.00$0.50$0.00$0.00$2.00

Dividend Yield & Payout


Dividend Yield

CVS Health Corporation has a dividend yield of 2.55%, which is quite average when compared to the overall market.

Payout Ratio

CVS Health Corporation has a payout ratio of 116.10%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the CVS Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CVS Health Corporation was 64.07%, occurring on Jan 30, 2003. Recovery took 614 trading sessions.

The current CVS Health Corporation drawdown is 4.99%.


Drawdown

Fall

Recovery

Underwater

Related event

-64.07%Jan 2003
1y 10mo2y 5mo
4y 4moMar 2001 - Jul 2005
-56.79%Dec 2024
2y 10mo1y 4mo
4y 3moFeb 2022 - May 2026
-50.11%Mar 2000
1y 11d8mo 7d
1y 8moFeb 1999 - Nov 2000
Dot-com crash2000–2002
-50.09%Apr 2019
3y 8mo2y 7mo
6y 3moJul 2015 - Nov 2021
-45.26%Mar 2009
9mo 6d2y 10mo
3y 7moJun 2008 - Jan 2012
Financial crisis2007–2009

Drawdown Indicators


CVSBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-64.07%

-56.78%

-7.29%

Max Drawdown (1Y)

Largest decline over 1 year

-16.44%

-9.10%

-7.34%

Max Drawdown (3Y)

Largest decline over 3 years

-43.98%

-18.90%

-25.08%

Max Drawdown (5Y)

Largest decline over 5 years

-56.79%

-25.43%

-31.36%

Max Drawdown (10Y)

Largest decline over 10 years

-56.79%

-33.92%

-22.87%

Current Drawdown

Current decline from peak

-4.99%

-1.58%

-3.41%

Average Drawdown

Average peak-to-trough decline

-19.48%

-10.70%

-8.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.66%

2.14%

+3.52%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of CVS Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how CVS Health Corporation is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for CVS, comparing it with other companies in the Healthcare Plans industry. Currently, CVS has a P/E ratio of 45.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CVS relative to other companies in the Healthcare Plans industry. Currently, CVS has a P/S ratio of 0.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CVS in comparison with other companies in the Healthcare Plans industry. Currently, CVS has a P/B value of 1.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with CVS

Add CVS Health Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with CVS